These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1691461)
1. Effects of a new cholecystokinin analogue (JMV 236) on food intake and brain monoamines in the rat. Gourch A; Orosco M; Rodriguez M; Martinez J; Cohen Y; Jacquot C Neuropeptides; 1990 Jan; 15(1):37-41. PubMed ID: 1691461 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds. Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054 [TBL] [Abstract][Full Text] [Related]
3. Comparative activity of two cholecystokinin analogues with partial agonist activity: effects on food intake and brain monoamines. Orosco M; Gourch A; Rodriguez M; Martinez J; Jacquot C; Cohen Y Peptides; 1990; 11(5):873-7. PubMed ID: 2284198 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid. Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048 [TBL] [Abstract][Full Text] [Related]
5. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors. Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of analogues of the Des-Phe-NH2 C-terminal hexapeptide of cholecystokinin showing gastrin antagonist activity. Laur J; Rodriguez M; Aumelas A; Bali JP; Martinez J Int J Pept Protein Res; 1986 Apr; 27(4):386-93. PubMed ID: 3710694 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of CCK-JMV-180 on food intake in rats and mice. Asin KE; Bednarz L Pharmacol Biochem Behav; 1992 Jun; 42(2):291-5. PubMed ID: 1631182 [TBL] [Abstract][Full Text] [Related]
8. A cholecystokinin agonist/antagonist according to dose and time of action: effect on food intake. Gourch A; Orosco M; Rodriguez M; Martinez J; Jacquot C; Cohen Y Neuropeptides; 1990 Dec; 17(4):187-91. PubMed ID: 2093151 [TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action. Schick RR; Yaksh TL; Go VL Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526 [TBL] [Abstract][Full Text] [Related]
10. Influence of cholecystokinin on central monoaminergic pathways. Widerlöv E; Kalivas PW; Lewis MH; Prange AJ; Breese GR Regul Pept; 1983 May; 6(2):99-109. PubMed ID: 6308717 [TBL] [Abstract][Full Text] [Related]
12. Similar potencies of CCK-8 and its analogue BOC(Nle28;Nle31)CCK27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogue. Heidbreder C; Roques BP; De Witte P Neuropeptides; 1989; 13(2):89-94. PubMed ID: 2739884 [TBL] [Abstract][Full Text] [Related]
13. Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180. Sato S; Stark HA; Martinez J; Beaven MA; Jensen RT; Gardner JD Am J Physiol; 1989 Aug; 257(2 Pt 1):G202-9. PubMed ID: 2475030 [TBL] [Abstract][Full Text] [Related]
14. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179. Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190 [TBL] [Abstract][Full Text] [Related]
15. Effects of the novel cholecystokinin analogue Suc-Trp-N(Me)-Nle-Asp-Phe-NH2 on feeding and cortisol release in pigs. Ebenezer IS; Parrott RF; Goode JA Pharmacol Biochem Behav; 1996 May; 54(1):255-9. PubMed ID: 8728566 [TBL] [Abstract][Full Text] [Related]
16. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species. Bianchi BR; Miller TR; Witte DG; Lin CW J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394 [TBL] [Abstract][Full Text] [Related]
17. Effect of anorexinergic peptides, cholecystokinin (CCK) and cocaine and amphetamine regulated transcript (CART) peptide, on the activity of neurons in hypothalamic structures of C57Bl/6 mice involved in the food intake regulation. Pirnik Z; Maixnerová J; Matysková R; Koutová D; Zelezná B; Maletínská L; Kiss A Peptides; 2010 Jan; 31(1):139-44. PubMed ID: 19818819 [TBL] [Abstract][Full Text] [Related]
18. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini. Sarri E; Ramos B; Salido GM; Claro E Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507 [TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin-induced variations in hypothalamic serotonergic system of the "cafeteria" rat. Orosco M; Gourch A; Cohen Y; Jacquot C Brain Res Bull; 1990 Dec; 25(6):949-52. PubMed ID: 1705163 [TBL] [Abstract][Full Text] [Related]
20. Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain. Arnelo U; Herrington MK; Theodorsson E; Adrian TE; Reidelberger R; Larsson J; Marcusson J; Strömmer L; Ding X; Permert J Brain Res; 2000 Dec; 887(2):391-8. PubMed ID: 11134629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]